Table: Mochida Pharm -Q1 group results

Mochida Pharmaceutical

01/08/2022 06:00

Aug 1 (Reuters)- 
             Mochida Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             27.69               27.36           105.00    
                 (+1.2 pct)          (-0.1 pct)       (-4.7 pct)  
  Operating          4.27                3.18             8.50    
                 (+34.0 pct)         (-30.7 pct)      (-40.9 pct) 
  Recurring          4.42                3.37             8.80    
                 (+31.2 pct)         (-28.9 pct)      (-40.5 pct) 
  Net                3.16                2.65             6.40    
                 (+18.9 pct)         (-21.2 pct)      (-39.4 pct) 
  EPS             83.98 yen           69.35 yen       170.35 yen  
  Ann Div                             90.00 yen        80.00 yen  
  -Q2 div                             40.00 yen        40.00 yen  
  -Q4 div                             50.00 yen        40.00 yen  
  
  NOTE - Mochida Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T